Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.

Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.

Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.